General description
A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs alprazolam; cimetidine; citalopram HBr; clonazepam; clopidogrel bisulfate; dextromethorphan; fluconazole; hydrochlorothiazide; lamotrigine; L-thyroxine; methylphenidate HCl; and omeprazole. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
grade: analytical standard. form: liquid. composition: Alprazolam, 100 . μ. g/mL , Cimetidine, 100 . μ. g/mL , Citalopram hydrobromide, 100 . μ. g/mL (as free base), Clonazepam, 100 . μ. g/mL , Clopidogrel bisulfate, 100 . μ. g/mL (as free base), Dextromethorphan, 50 . μ. g/mL , Fluconazole, 100 . μ. g/mL , Hydrochlorothiazide, 100 . μ. g/mL , Lamotrigine, 100 . μ. g/mL , Methylphenidate hydrochloride, 100 . μ. g/mL (as free base), Omeprazole, 100 . μ. g/mL , L-Thyroxine, 5 . μ. g/mL . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . drug control: psicótropo (Spain). Decreto Lei 15/93: Tabela IV/IIB (Portugal). concentration: 5-100 . μ. g/mL each component in methanol. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): forensics and toxicology. format: single component solution. storage temp.: −. 20°C. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 41103807
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- I-026-1ML
- Temperature Control Device:
- Yes
- DEA:
- Yes
akash.verma@cenmed.com
(732) 447-1115





